2130 Federal Register / Vol. 76, No. 8 / Wednesday, January 12, 2011 / Notices 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.ninds.nih.gov, where and agenda and 

any additional information for the meeting 

will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: January 5, 2011. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2011–577 Filed 1–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Inhibitors of the Plasmodial 

Surface Anion Channel as 

Antimalarials 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health, Department of 

Health and Human Services, is 

contemplating the grant of an exclusive 

patent license to practice the inventions 

embodied in U.S. Provisional Patent 

Application No. 61/083,000, filed July 

23, 2008 [HHS Ref. No. E–202–2008/0– 

US–01], now expired and PCT Patent 

Application No. PCT/US09/50637 [HHS 

Ref. No. E–202–2008/0–PCT–02] filed 

July 15, 2009, which published as WO/ 

2010/011537 on January 28, 2010, both 

applications entitled ‘‘Inhibitors of the 

Plasmodial Surface Anion Channel As 

Antimalarials,’’ and all continuing 

applications and foreign counterparts to 

Microbiotix, Inc., having a place of 

business in Worcester, Massachusetts. 

The patent rights in these inventions 

have been assigned to the United States 

of America. 

The prospective exclusive license 

territory may be ‘‘worldwide’’, and the 

field of use may be limited to 

‘‘prevention and treatment of malaria in 

humans.’’ 

DATES: Only written comments and/or 

applications for a license which are 

received by the NIH Office of 

Technology Transfer on or before 

February 11, 2011 will be considered. 

ADDRESSES: Requests for copies of the 

patent application, inquiries, comments, 

and other materials relating to the 

contemplated exclusive license should 

be directed to: Kevin W. Chang, PhD, 

Senior Licensing and Patenting 

Manager, Office of Technology Transfer, 

National Institutes of Health, 6011 

Executive Boulevard, Suite 325, 

Rockville, MD 20852–3804; Telephone: 

(301) 435–5018; Facsimile: (301) 402– 

0220; E-mail: changke@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The 

subject technologies are antimalarial 

small molecule inhibitors of the 

plasmodial surface anion channel 

(PSAC), an essential nutrient acquisition 

ion channel expressed on human 

erythrocytes infected with malaria 

parasites. These inhibitors were 

discovered by high-throughput 

screening of chemical libraries and 

analysis of their ability to kill malaria 

parasites in culture. Two separate 

classes of inhibitors were found to work 

synergistically in combination against 

PSAC and killed malaria cultures at 

markedly lower concentrations than 

separately. These inhibitors have high 

affinity and specificity for PSAC and 

have acceptable cytotoxicity profiles. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless 

within thirty (30) days from the date of 

this published notice, the NIH receives 

written evidence and argument that 

establishes that the grant of the license 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR 404.7. 

Applications for a license in the field 

of use filed in response to this notice 

will be treated as objections to the grant 

of the contemplated exclusive license. 

Comments and objections submitted to 

this notice will not be made available 

for public inspection and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552. 

Dated: January 6, 2011. 

Richard U. Rodriguez, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health. 

[FR Doc. 2011–549 Filed 1–11–11; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Office of the Secretary 

Exercise of Authority Under Section 

212(d)(3)(B)(i) of the Immigration and 

Nationality Act 

AGENCY: Office of the Secretary, DHS. 

ACTION: Notice of determination. 

Authority: 8 U.S.C. 1182(d)(3)(B)(i). 

Following consultations with the 

Secretary of State and the Attorney 

General, I hereby conclude, as a matter 

of discretion in accordance with the 

authority granted to me by section 

212(d)(3)(B)(i) of the Immigration and 

Nationality Act (INA), 8 U.S.C. 

1182(d)(3)(B)(i), as amended, as well as 

the foreign policy and national security 

interests deemed relevant in these 

consultations, that subsection 

212(a)(3)(B)(iv)(VI) of the INA, 8 U.S.C. 

1182(a)(3)(B)(iv)(VI), shall not apply, 

with respect to an alien, for the 

provision of material support to the All 

India Sikh Students Federation-Bittu 

Faction, provided that the alien satisfies 

the relevant agency authority that the 

alien: 

(a) Is seeking a benefit or protection 

under the INA and has been determined 

to be otherwise eligible for the benefit 

or protection; 

(b) Has undergone and passed all 

relevant background and security 

checks; 

(c) Has fully disclosed, to the best of 

his or her knowledge, in all relevant 

applications and interviews with U.S. 

government representatives and agents, 

the nature and circumstances of each 

provision of material support and any 

other activity or association falling 

within the scope of section 212(a)(3)(B) 

of the INA, 8 U.S.C. 1182(a)(3)(B); 

(d) Has not participated in, or 

knowingly provided material support to, 

terrorist activities that targeted 

noncombatant persons or U.S. interests; 

(e) Poses no danger to the safety and 

security of the United States; and 

(f) Warrants an exemption from the 

relevant inadmissibility provision in the 

totality of the circumstances. 

Implementation of this determination 

will be made by U.S. Citizenship and 

Immigration Services (USCIS), in 

consultation with U.S. Immigration and 

Customs Enforcement (ICE), or by U.S. 

consular officers, as applicable, who 

shall ascertain, to their satisfaction, and 

in their discretion, that the particular 

applicant meets each of the criteria set 

forth above. 

This exercise of authority may be 

revoked as a matter of discretion and 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 76, No. 8 / Wednesday, January 12, 2011 / Notices 2131 

without notice at any time, with respect 

to any and all persons subject to it. Any 

determination made under this exercise 

of authority as set out above can inform 

but shall not control a decision 

regarding any subsequent benefit or 

protection application, unless such 

exercise of authority has been revoked. 

This exercise of authority shall not be 

construed to prejudice, in any way, the 

ability of the U.S. government to 

commence subsequent criminal or civil 

proceedings in accordance with U.S. 

law involving any beneficiary of this 

exercise of authority (or any other 

person). This exercise of authority 

creates no substantive or procedural 

right or benefit that is legally 

enforceable by any party against the 

United States or its agencies or officers 

or any other person. 

In accordance with section 

212(d)(3)(B)(ii) of the INA, 8 U.S.C. 

1182(d)(3)(B)(ii), a report on the aliens 

to whom this exercise of authority is 

applied, on the basis of case-by-case 

decisions by the U.S. Department of 

Homeland Security or by the U.S. 

Department of State, shall be provided 

to the specified congressional 

committees not later than 90 days after 

the end of the fiscal year. 

This determination is based on an 

assessment related to the national 

security and foreign policy interests of 

the United States as they apply to the 

particular persons described herein and 

shall not have any application with 

respect to other persons or to other 

provisions of U.S. law. 

Dated: October 18, 2010. 

Janet Napolitano, 

Secretary of Homeland Security. 

[FR Doc. 2011–425 Filed 1–11–11; 8:45 am] 

BILLING CODE 9110–9M–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Office of the Secretary 

Exercise of Authority Under Section 

212(d)(3)(B)(i) of the Immigration and 

Nationality Act 

AGENCY: Office of the Secretary, DHS. 

ACTION: Notice of Determination. 

Authority: 8 U.S.C. 1182(d)(3)(B)(i). 

Following consultations with the 

Secretary of State and the Attorney 

General, I hereby conclude, as a matter 

of discretion in accordance with the 

authority granted to me by section 

212(d)(3)(B)(i) of the Immigration and 

Nationality Act (INA), 8 U.S.C. 

1182(d)(3)(B)(i), as amended, as well as 

the foreign policy and national security 

interests deemed relevant in these 

consultations, that section 212(a)(3)(B) 

of the INA, 8 U.S.C. 1182(a)(3)(B), 

excluding subclause (i)(II), shall not 

apply, with respect to an alien, for any 

activity or association relating to the All 

Burma Students’ Democratic Front 

(ABSDF), provided that the alien 

satisfies the relevant agency authority 

that the alien: 

(a) Is seeking a benefit or protection 

under the INA and has been determined 

to be otherwise eligible for the benefit 

or protection; 

(b) Has undergone and passed all 

relevant background and security 

checks; 

(c) Has fully disclosed, to the best of 

his or her knowledge, in all relevant 

applications and interviews with U.S. 

government representatives and agents, 

the nature and circumstances of 

activities or associations falling within 

the scope of section 212(a)(3)(B) of the 

INA, 8 U.S.C. 1182(a)(3)(B); 

(d) Has not participated in, or 

knowingly provided material support to, 

terrorist activities that targeted 

noncombatant persons or U.S. interests; 

(e) Poses no danger to the safety and 

security of the United States; and 

(f) Warrants an exemption from the 

relevant inadmissibility provision in the 

totality of the circumstances. 

Implementation of this determination 

will be made by U.S. Citizenship and 

Immigration Services (USCIS), in 

consultation with U.S. Immigration and 

Customs Enforcement (ICE), or by U.S. 

consular officers, as applicable, who 

shall ascertain, to their satisfaction, and 

in their discretion, that the particular 

applicant meets each of the criteria set 

forth above. 

This exercise of authority may be 

revoked as a matter of discretion and 

without notice at any time, with respect 

to any and all persons subject to it. Any 

determination made under this exercise 

of authority as set out above can inform 

but shall not control a decision 

regarding any subsequent benefit or 

protection applications, unless such 

exercise of authority has been revoked. 

This exercise of authority shall not be 

construed to prejudice, in any way, the 

ability of the U.S. government to 

commence subsequent criminal or civil 

proceedings in accordance with U.S. 

law involving any beneficiary of this 

exercise of authority (or any other 

person). This exercise of authority 

creates no substantive or procedural 

right or benefit that is legally 

enforceable by any party against the 

United States or its agencies or officers 

or any other person. 

In accordance with section 

212(d)(3)(B)(ii) of the INA, 8 U.S.C. 

1182(d)(3)(B)(ii), a report on the aliens 

to whom this exercise of authority is 

applied, on the basis of case-by-case 

decisions by the U.S. Department of 

Homeland Security or by the U.S. 

Department of State, shall be provided 

to the specified congressional 

committees not later than 90 days after 

the end of the fiscal year. 

This determination is based on an 

assessment related to the national 

security and foreign policy interests of 

the United States as they apply to the 

particular persons described herein and 

shall not have any application with 

respect to other persons or to other 

provisions of U.S. law. 

Dated: December 16, 2010. 

Janet Napolitano, 

Secretary of Homeland Security. 

[FR Doc. 2011–426 Filed 1–11–11; 8:45 am] 

BILLING CODE 9110–9M–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID FEMA–2010–0032] 

Federal Radiological Preparedness 

Coordinating Committee 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice of public meeting. 

SUMMARY: The Federal Radiological 

Preparedness Coordinating Committee 

(FRPCC) is holding a public meeting on 

January 20, 2011 in Arlington, VA. 

DATES: The meeting will take place on 

January 20, 2011. The session open to 

the public will be from 9 a.m. EST to 10 

a.m. EST. Send written statements and 

requests to make oral statements to the 

contact person listed under the FOR

FURTHER INFORMATION CONTACT caption 

by close of business January 14, 2011. 

ADDRESSES: The meeting will be held at 

the Crystal City Marriott at Reagan 

National Airport located at 1999 

Jefferson Davis Highway, Arlington, VA 

22202, in Salon E & F. 

FOR FURTHER INFORMATION CONTACT: 

Timothy Greten, FRPCC Executive 

Secretary, DHS/FEMA, 1800 South Bell 

Street—CC847, Mail Stop 3025, 

Arlington, VA 20598–3025; telephone 

(202) 646–3907; fax (703) 305–0837; or 

e-mail timothy.greten@dhs.gov. 

SUPPLEMENTARY INFORMATION: The role 

and functions of the Federal 

Radiological Preparedness Coordinating 

Committee (FRPCC) are described in 44 

mstockstill on DSKH9S0YB1PROD with NOTICES